Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
639 Leser
Artikel bewerten:
(2)

Canada Drugs Direct; US Consumers Soon to Have Readier Access to Prescription Medications from Canada

SURREY, BC / ACCESSWIRE / August 29, 2019 / The Following is a statement from Canada Drugs Direct - "A proposal coming from the White House and President Trump that would allow the US to import drugs from Canada is in its formative stages. The US FDA's current regulations prohibiting medications from other countries being imported for personal use are coming to an end. The current administration is finally taking action in response to the wish for more competition and lower prices in the pharmaceuticals market. This also has Canadian pharmacies standing to benefit, and quite significantly given the enormity of the US consumer base.

News from Washington that the current administration is ready to take action on plans suggested by US lawmakers who have laid out how ongoing and ever-increasing high prescription drug costs in America can be countered with freer access to prescription medication from Canada. Such a move has been resisted in the past due to concerns for consumer safety, but President Trump has said he sees a need for transparency with drug prices and lower costs for people who find the costs of their medication to be prohibitive.

Prescription drugs can be purchased at lower prices from Canada for a number of reasons, but the primary one is price capping. This stipulation makes it so that that cost of a new drug cannot be higher than the cost of existing drugs used to treat the same disease. The second part of price capping for medications in Canada is a review-board policy where 'international reference pricing' is used to keep costs in line with those seen elsewhere around the World. Lesser factors are legal protection adding to drug costs in America and the way Canada has prohibited direct-to-consumer advertising used in the USA."

Canada Drugs Direct is one Canadian online pharmacy who's ideally situated to meet the demand for prescription medications from Canada. In addition to having the majority of the most commonly-prescribed medications in America in stock and ready for shipment, they've done well in establishing themselves a reputable business that puts a premium on quality products and first-rate customer service to go along with full adherence to responsible and law-abiding dispensing of medications exactly as written by the prescribing physician.

Customers choosing Canada Pharmacy Online also stand to benefit from being able to place orders quickly and easily through the website, and knowing the transaction is 100% secure with CDD's advanced encryption SSL certificates in place at all times. Canada Drugs Direct is also CIPA (Canadian International Pharmacy Association) certified.

About the Company

Canada Drugs Direct is one of the largest online pharmacies in Canada. The company has been built into a leading online pharmacy that's able to provide the best value for prescription drugs along with excellent customer service.

They are pleased to be able to offer a wide range of over-the-counter (OTC) medications for both people and their pets. For more information about Canada Drugs Direct, please visit the company's website at https://www.canadadrugsdirect.com.

Contact: Canada Drugs Direct
Company: Canada Drugs Direct
Address: PO Box 520 , 800-15355 24th Avenue Surrey, BC/ Canada V4A H9 Canada
Contact Number: 1-888-904-8467
Email: marketing@canadadrugsdirect.com
Website: https://www.canadadrugsdirect.com/

SOURCE: Canada Drugs Direct



View source version on accesswire.com:
https://www.accesswire.com/557854/Canada-Drugs-Direct-US-Consumers-Soon-to-Have-Readier-Access-to-Prescription-Medications-from-Canada

© 2019 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.